How many institutional investors hold NVS?

4 tracked institutional investors disclosed a position in NVS (NOVARTIS AG) in their most recent 13F filing.

Who is the largest institutional holder of NVS?

Ken Griffin, Citadel Advisors, holds the largest disclosed position in NVS, valued at $162M.

Where does this NVS ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

NVS — NOVARTIS AG

Name: NOVARTIS AG (NVS) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying NVS?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence

Institutional Conviction

Net accumulation · 1 buying vs 0 selling last quarter

Macro Tailwind

Macro conditions are mixed for this sector

Congressional Activity

2 congressional purchases, 0 sales disclosed in the last 6 months

Why? — Evidence & Confidence ▾

Of 1 tracked investors who changed their NVS position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 56/100 in a Overheat regime). 2 congressional purchases, 0 sales disclosed in the last 6 months.

Supporting evidence

+1 tracked investor added or increased positions last quarter (Ken Griffin)
+4 tracked investors reported holding NVS at their latest filing
+Macro Health is 56/100 in a Overheat regime — historically acceptable for this sectorsource
+2 congressional purchases disclosed in the last 6 months

Contradicting evidence — always shown

−13F data is disclosed up to 45 days after quarter end — positions may have changed since

Know the limits

· 13F disclosure lag (up to 45 days)
· Tracked investors are a sample, not the whole market
· Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About NOVARTIS AG (NVS)

NOVARTIS AG (NVS) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $162M. Across recent filings, tracked investors recorded 3 new positions, 2 increased, 1 reduced, and 2 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in NVS

/100

Institutional Accumulation

Added / Increased5

Reduced1

Exited2

BearishBullish

Crowded Trade Score™

How many top investors track NVS

/100

Emerging Interest

4investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

NVS Ownership Composition

How NOVARTIS AG is held across tracked investor types, based on reported 13F positions.

Dominant Type

Multi-Strategy / Quant

98% of tracked value

Institutions

tracked investors

Total Reported

$345.3M

combined 13F value

Multi-Strategy / Quant97.8%
Macro2.2%

Multi-Strategy / Quant(3)

97.8%

Macro(1)

2.2%

Tracked investors currently reporting NVS

Investor	Firm	Shares	Market value	% of portfolio	As of
Ken Griffin	Citadel Advisors	1M	$162.1M	0.02%	Jun 30, 2026
Steve Cohen	Point72 Asset Management	318.6K	$49.9M	0.06%	Jun 30, 2026
Izzy Englander	Millennium Management	800.6K	$125.5M	0.05%	Jun 30, 2026
Paul Tudor Jones	Tudor Investment Corp	49.5K	$7.8M	0.01%	Jun 30, 2026

Ken GriffinJun 30, 2026
Citadel Advisors
Shares
1M
Value
$162.1M
% Portfolio
0.02%
Steve CohenJun 30, 2026
Point72 Asset Management
Shares
318.6K
Value
$49.9M
% Portfolio
0.06%
Izzy EnglanderJun 30, 2026
Millennium Management
Shares
800.6K
Value
$125.5M
% Portfolio
0.05%
Paul Tudor JonesJun 30, 2026
Tudor Investment Corp
Shares
49.5K
Value
$7.8M
% Portfolio
0.01%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Ken Griffin	New	—	$75.6K	Nov 14, 2025
Ken Griffin	Increased	7.29%	$87.2K	Feb 17, 2026
Steve Cohen	New	—	$15M	Nov 14, 2024
Steve Cohen	Reduced	-76.43%	$3M	Feb 14, 2025
Steve Cohen	Increased	3841.80%	$135.3M	Jul 21, 2025
Steve Cohen	Sold	-100.00%	$0	Aug 14, 2025
Paul Tudor Jones	Sold	-100.00%	$0	Aug 14, 2024
Paul Tudor Jones	New	—	$374.8K	May 15, 2024

Ken Griffin
New
$75.6KNov 14, 2025
Ken Griffin
Increased
$87.2K(7.29%)Feb 17, 2026
Steve Cohen
New
$15MNov 14, 2024
Steve Cohen
Reduced
$3M(-76.43%)Feb 14, 2025
Steve Cohen
Increased
$135.3M(3841.80%)Jul 21, 2025
Steve Cohen
Sold
$0(-100.00%)Aug 14, 2025
Paul Tudor Jones
Sold
$0(-100.00%)Aug 14, 2024
Paul Tudor Jones
New
$374.8KMay 15, 2024

Frequently asked questions

How many institutional investors hold NVS?: 4 tracked institutional investors disclosed a position in NVS (NOVARTIS AG) in their most recent 13F filing.
Who is the largest institutional holder of NVS?: Ken Griffin, Citadel Advisors, holds the largest disclosed position in NVS, valued at $162M.
Did institutional ownership of NVS increase or decrease?: Across recent 13F filings, tracked investors recorded 3 new positions, 2 increased, 1 reduced, and 2 fully exited NVS.
Where does this NVS ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.